Stanford researchers develop treatment that restores cartilage and reverses arthritis in mice and human tissue
Stanford Medicine researchers have shown that blocking a protein called 15-PGDH can regrow lost knee cartilage in older mice, prevent post-injury arthritis, and stimulate new cartilage production in human tissue samples. The protein is a "gerozyme" that increases with age and suppresses tissue regeneration by breaking down prostaglandin E2, a molecule critical for cellular repair. The findings, published in Science, raise the possibility of injectable or oral treatments that could address the root cause of osteoarthritis rather than merely managing its symptoms.
A Stanford Medicine-led study published in the journal Science reports that inhibiting the protein 15-PGDH dramatically restored knee cartilage in aged mice and prevented osteoarthritis from developing after ACL-type injuries. The treatment works by blocking a gerozyme — a class of proteins that accumulates with age and degrades prostaglandin E2, a molecule needed for tissue regeneration. Unlike conventional regeneration, which relies on stem cells, the mechanism appears to reprogram existing cartilage-producing cells called chondrocytes, shifting their gene expression toward a younger, healthier state. In treated older mice, the proportion of cells building healthy hyaline cartilage nearly doubled, while cartilage-degrading cell populations shrank significantly. Crucially, human cartilage tissue removed during knee replacement surgeries also responded to the treatment, producing new articular cartilage after one week of exposure. An oral form of a 15-PGDH inhibitor has already completed Phase 1 clinical trials for age-related muscle weakness and was found to be safe in healthy volunteers. The researchers note that several authors hold patents and equity in Epirium Bio, a company licensed to develop 15-PGDH inhibitors, representing a potential conflict of interest.
What's missing
The study has not yet been tested in living humans; results in human tissue samples ex vivo do not confirm efficacy or safety in a clinical setting. The article does not report the sample sizes used in mouse or human tissue experiments, limiting assessment of statistical robustness. Long-term effects of sustained 15-PGDH inhibition — including potential risks from elevated prostaglandin E2 levels systemically — are not addressed.
What different sources said
- Science DailyCenter
Stanford scientists regrow lost cartilage and reverse arthritis in major breakthrough
Related
Chicago Woman's Five-Year Symptom Journey Leads to Rare Brain Tumor Diagnosis
Melony Aponte, 26, was diagnosed with a 4.5-centimeter acoustic neuroma after five years of symptoms she attributed to stress, COVID-19, and aging. The rare, noncancerous tumor—affecting roughly one in 100,000 people—had grown large enough to compress her hearing and balance nerve before it was identified via MRI in March 2025. Her case highlights how acoustic neuroma symptoms can mimic common conditions, potentially delaying diagnosis for years.
Study Finds Aging Shifts Walking Strategy Toward Stability at the Cost of Efficiency
A new study from Flinders University and the University of Canberra found that as people age, their bodies adopt a 'safety-first' walking pattern that prioritizes balance over efficient movement. Researchers analyzed gait data from 107 healthy adults aged 26 to 86, identifying increased ankle muscle co-contraction and reduced push-off power as key age-related changes. The findings suggest that fall prevention programs should target balance and coordination, not just muscle strength.
Tick Populations Surge in Urban Areas Across Northeast
Experts across the northeastern United States and Canada are warning of an unusually early and widespread tick season, with disease-carrying ticks increasingly found in urban parks and green spaces. Lyme disease cases in Canada reached a record 7,105 in 2025, up from 5,809 the previous year, while U.S. cities including Philadelphia, Pittsburgh, Washington D.C., and New York are reporting rising tick activity. The expansion poses a public health challenge because urban residents are less likely to take tick-bite precautions than those in rural areas.